New World Medical Introduces Next-Generation STREAMLINE(R) Surgical System

May 14, 2025 8:00 AM

New World Medical is pleased to announce the launch of its enhanced STREAMLINE® Surgical System, featuring a transparent tip designed to provide surgeons with improved visualization of key anatomical structures throughout the procedure. This latest advancement builds upon the proven foundation of the original STREAMLINE® Surgical System platform - an implant-free, minimally invasive solution that integrates seamlessly into cataract surgery...

Read more

Water Tower Research Highlights Ainos' Significant Commercial Traction and Strategic Milestones Across Multiple Sectors

May 14, 2025 8:00 AM

Ainos, Inc. (Nasdaq:AIMD)(Nasdaq:AIMDW) ("Ainos"), a leader in AI-powered scent digitization, today announced that Water Tower Research ("WTR") has published a report highlighting the Company's significant progress in commercializing its AI-driven scent digitization platform, AI Nose, and expanding into multiple market verticals. Notably, Ainos has achieved a key milestone of achieving over 80% accuracy in its senior care project.Key Highlights...

Read more

Best SARMs for Cutting and Bulking, Fat Loss and Extreme Muscle Gains and Growth | Legal Natural Selections for Safe Bodybuilding

May 14, 2025 7:45 AM

Introductory note SARMs are a class of drugs (still in the research stage) that provide an action similar to anabolic steroids, however, with a fundamental difference.Their selective action (in limited body tissues) is more "friendly" to the organism and causes significantly fewer side effects.As this unique ability of SARMs became known - immediately - they became rampant in the field of bodybuilding, illegally.Although not all SARMs fall into...

Read more

New Improvements Coming to Hoggan Scientific's microFET2 Handheld Dynamometer

May 14, 2025 7:00 AM

Hoggan Scientific, LLC, a global leader in medical dynamometers and industrial force gauges, is proud to announce new features and accessories for its microFET2 flagship handheld dynamometer-a trusted tool for objective muscle strength assessments. The enhancements are driven by strong market demand and direct feedback from healthcare professionals, underscoring the company's commitment to innovation and user-centered design. One of the most...

Read more

Measles Cases Are Increasing Globally; MPox Continues to Be a Threat - Broad-Spectrum Antiviral Drug Could Be the Solution

May 14, 2025 6:30 AM

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, explains its drug development strategy to combat important global viral threats.Measles outbreaks have continued to expand in the US, and the dramatic ten-fold increase in annual Measles cases in...

Read more

Automated Insights in Action: Kyowa Interface Science Enhances Discovery With Bioz Badges

May 14, 2025 4:00 AM

Bioz, Inc., a trusted innovator in AI-powered literature analysis and product credibility for science, is proud to showcase its expanding collaboration with Kyowa Interface Science, a leading force in contact angle and surface measurement instrumentation based in Japan. Through the integration of Bioz Badges, Kyowa is delivering a seamless and transparent user experience that connects researchers with real-world applications of their products.By...

Read more

Hemogenyx Pharmaceuticals PLC Announces Pediatric Amendment to Clinical Protocol

May 14, 2025 2:00 AM

Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that it has filed an amendment to the clinical protocol for its ongoing Phase I clinical trial of HG-CT-1 to include pediatric patients with relapsed/refractory acute myeloid leukemia ("R/R AML"). HG-CT-1 is the Company's CAR-T therapy, currently undergoing clinical trials in adults for the treatment of R/R AML.This amendment, filed with the U.S. Food and Drug Administration (FDA),...

Read more

Gummi World Enters Capsule Manufacturing, Emerging as the Most Agile Full-Spectrum Supplement Manufacturer in the Industry

May 14, 2025 2:00 AM

Gummi World, the most certified gummy supplement manufacturer in the industry and a wholly owned subsidiary of Intiva Health Group, has officially launched high-volume capsule production, expanding its vertically integrated manufacturing platform to include both gummies and capsules under one certified roof. The move strengthens the company's position as a one-stop partner for global brands seeking clean-label, scalable, and clinically guided...

Read more

Teva's 2024 Healthy Future Report Highlights Sustainability Progress, Including Surpassed Targets Linked to Financial Strategy

May 13, 2025 4:45 PM

Teva PharmaceuticalThe Company achieved a 29% reduction in absolute scope 1 and 2 greenhouse gas emissions from 2019 levels, surpassing its target of 25% by 2025, ahead of scheduleTeva launched two new programs to help people around the world access the medicines they need, for a total of nine programs, surpassing its target of eight programs by 2025More than 99% of Teva employees were trained on compliance and ethics, and more than 40% of its...

Read more

NHI Responds to ISS Recommendation

May 13, 2025 4:30 PM

National Health Investors, Inc. (NYSE:NHI) ("NHI" or "the Company") issued the following statement regarding a May 12, 2025 report by proxy advisory firm Institutional Shareholder Services ("ISS"):We strongly disagree with ISS' recommendation which we believe would disrupt the momentum that NHI, under the guidance of our Board, has created to capitalize on the significant growth opportunity in the senior housing industry and that has resulted in...

Read more

Ensysce Biosciences Reports First Quarter 2025 Financial Results

May 13, 2025 4:15 PM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, today reported financial and operational results for the first quarter ended March 31, 2025.Dr Lynn Kirkpatrick, Chief Executive Officer of Ensysce, commented, "We are pleased with the meaningful strides the Company has...

Read more

Tenon Medical Reports First Quarter 2025 Financial Results

May 13, 2025 4:05 PM

Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today reported financial results for the first quarter ended March 31, 2025.Financial Results and Business UpdatesFirst Quarter 2025 Results:Revenue of $0.7 million, in line with the first quarter of 2024.Gross profit of $323,000, as compared to $470,000 in the first quarter of...

Read more

Dr. Harrell E. Robinson Advocates for Global Access to Healthcare

May 13, 2025 3:30 PM

In a recent feature interview titled "Dr. Harrell E. Robinson: From Alabama Roots to Global Health Leader", physician, humanitarian, and CEO Dr. Harrell E. Robinson is calling for increased awareness and support for healthcare access in underserved regions around the world. Drawing from his decades of medical practice and international outreach, Dr. Robinson is urging individuals to take initiative in contributing to health equity globally."We...

Read more

Dr. Malini Saba Featured in In-Depth Spotlight Article Highlighting Her Journey from Entrepreneur to Global Changemaker

May 13, 2025 3:00 PM

Dr. Malini Saba, a globally respected entrepreneur, psychologist, and philanthropist, is the subject of a newly published online feature article that offers an intimate look at her extraordinary journey through business, philanthropy, and personal transformation. The article presents a compelling narrative that blends her professional milestones with the personal philosophies that drive her work.The feature, written in an accessible and...

Read more

Theranexus and Beyond Batten Disease Foundation Announce Strong Positive Real-World Data Supporting Batten-1 Efficacy for the Treatment of Batten Disease

May 13, 2025 1:20 PM

LYON, FRANCE and AUSTIN, TX / ACCESS Newswire / May 13, 2025 / Theranexus, a biopharmaceutical company developing drug candidates for rare neurological diseases, and the Beyond Batten Disease Foundation (BBDF) today announced new real-world data strongly supporting the efficacy of Batten-1 (miglustat) as a treatment for CLN3 disease, also known as juvenile Batten disease.The analysis evaluated visual acuity outcomes in CLN3 patients treated with...

Read more

Neighborhood LTC Pharmacy Announces New Partnership With ES Gaming Powered by Easterseals

May 13, 2025 1:00 PM

Neighborhood LTC Pharmacy, a leader in pharmacy services for individuals with Intellectual and Developmental Disabilities (IDD), is thrilled to announce its partnership with ES Gaming, powered by Easterseals, marking a significant step towards creating more accessible and engaging community spaces in our increasingly digital world. This collaboration is set to address the unique challenges individuals with IDD may face when accessing online...

Read more

CERTIFY Health Secures Growth Equity Investment from ABS Capital Partners to Accelerate Patient Engagement Innovation

May 13, 2025 12:30 PM

CERTIFY Health, a leading SaaS patient engagement platform, is excited to announce its Series A funding round from ABS Capital Partners. This strategic growth equity investment will fuel CERTIFY Health's mission of enhancing the patient experience and streamlining clinical practice operations by expanding its digital intake products and payment solutions.Since its founding in 2012, CERTIFY Health has delivered innovative tools that simplify...

Read more

CNS Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

May 13, 2025 9:35 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced the pricing of its "reasonable best efforts" public offering with a single healthcare focused institutional investor for the purchase and sale of 3,952,570 shares of common stock of the Company (the "Common...

Read more

Hypha Labs Files Multiple Additional Patents for its Ground Breaking Mushroom Accelerator

May 13, 2025 9:15 AM

Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce the filing of additional patents with the United States Patent and Trade Office (USPTO) which it believes further protects the Company's innovations in the commercialization of a broad array of functional mushroom ingredients for the rapidly growing consumer and enterprise markets.The three...

Read more

Ankle & Foot Centers of America Shares Advice on the Best Running Shoes for National Runners Month

May 13, 2025 9:01 AM

In honor of National Runners Month this May, Ankle & Foot Centers of America is offering expert insight on how the right footwear can help runners avoid common issues like plantar fasciitis, arch strain, and ankle pain. With thousands of runners lacing up this season, foot health starts from the ground up."Running is excellent for cardiovascular health, but we frequently treat runners suffering from arch or heel pain due to inadequate footwear,"...

Read more